ѻý

<ѻý class="page-title">Meeting Coverage

NACLC

<ѻý class="page-description">North America Conference on Lung Cancer
CDK4/6 Inhibitor in SCLC Cuts Chemo-Induced Myelosuppression

Reduced severe neutropenia and less need for supportive care with trilaciclib

NACLC over a computer rendering of lung cancer
<ѻý class="section_title">Latest NACLC Meeting Coverage
Dual Checkpoint Blockade With Some Chemo Boosts OS in NSCLC

Nivolumab-ipilimumab with two cycles of chemotherapy improved survival, regardless of histology or PD-L1 status

October 17, 2020